These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8566691)

  • 21. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 22. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
    Morosetti M; Sciarra G; Meloni C; Palmieri G; Palombo G; Taccone Gallucci M; Casciani CU
    Nephrol Dial Transplant; 1996 Mar; 11(3):532-4. PubMed ID: 8671827
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Should hepatitis C be treated?].
    Tran A
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hepatitis C with interferon-alpha in hemodialysis patients].
    Degos F
    Nephrologie; 1997; 18(7):279-80. PubMed ID: 9496567
    [No Abstract]   [Full Text] [Related]  

  • 27. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
    Tambini R; Quattrini A; Fracassetti O; Nemni R
    J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical use of interferons in hepatology.
    Civeira MP
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
    [No Abstract]   [Full Text] [Related]  

  • 32. Extrahepatic manifestations of chronic viral hepatitis.
    Willson RA
    Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination].
    Glück T; Dürk H; Kötter I; Zimmermann C; Saal JG
    Med Klin (Munich); 1995 Dec; 90(12):674-80. PubMed ID: 8583982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon-alpha in chronic hepatitis C].
    Swobodnik W
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1186. PubMed ID: 7656857
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and treatment of viral hepatitis C].
    Bogomolov BP; Kostiunina MK
    Klin Med (Mosk); 1997; 75(9):62-4. PubMed ID: 9432548
    [No Abstract]   [Full Text] [Related]  

  • 38. A rational approach to hepatitis C.
    Mills P; McPeake J; McCruden E
    Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic viral hepatitis due to the hepatitis C virus (HCV): treatment experience with lymphoblast interferon-alpha].
    Foti G; De Cicco M; Masseo A; Mangano C; Tripodi A; Foti N
    Minerva Med; 1996; 87(1-2):53-5. PubMed ID: 8610026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.